|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation of premises and equipment, net | |||||
| Accretion of fees, premiums and discounts, net | |||||
| Amortization of intangible assets | |||||
| Amortization of right of use lease asset | |||||
| Decrease in operating lease liability | |||||
| Income from mortgage banking activities, net | |||||
| Gain on sale of securities, net | |||||
| Loss on sale of other real estate owned and valuation adjustments, net | |||||
| Stock-based compensation expense | |||||
| Unrealized loss (gain) on equity investments, net | |||||
| Realized gain on sale of equity investment, net | |||||
| Gain on sale of WSFS Wealth Management, LLC business | |||||
| Deferred income tax expense (benefit) | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Decrease (increase) in other assets | |||||
| Origination of loans held-for-sale | |||||
| Proceeds from sales of loans held-for-sale | |||||
| (Decrease) increase in accrued interest payable | |||||
| (Decrease) increase in other liabilities | |||||
| Increase in value of bank-owned life insurance | |||||
| Increase in capitalized interest, net | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of investment securities held to maturity | |||||
| Repayments, maturities and calls of investment securities held to maturity | |||||
| Sale of investment securities available-for-sale | |||||
| Purchases of investment securities available-for-sale | |||||
| Repayments of investment securities available-for-sale | |||||
| Proceeds from bank-owned life insurance death benefit | |||||
| Proceeds from bank-owned life insurance surrender | |||||
| Net proceeds from sale of equity investments | |||||
| Net cash paid for business combinations | |||||
| Net increase in loans and leases | |||||
| Net cash from sale of WSFS Wealth Management, LLC business | |||||
| Purchases of loans held for investment | |||||
| Purchases of FHLB stock | |||||
| Redemption of FHLB stock | |||||
| Sales of assets acquired through foreclosure, net | |||||
| Sale of premise and equipment | |||||
| Investment in premises and equipment, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Net increase (decrease) in demand and saving deposits | |||||
| (Decrease) increase in time deposits | |||||
| Decrease in brokered deposits | |||||
| Receipts from FHLB advances | |||||
| Repayments of FHLB advances | |||||
| Receipts from federal funds purchased | |||||
| Repayments of federal funds purchased | |||||
| Receipts from Bank Term Funding Program | |||||
| Repayments of Bank Term Funding Program | |||||
| Contributions from (distributions to) noncontrolling shareholders | |||||
| Cash dividends | |||||
| Issuance of common stock and exercise of common stock options | |||||
| Redemption of senior and subordinated debt | |||||
| Receipts from issuance of senior debt | |||||
| Senior debt issuance costs | |||||
| Repurchase of common shares | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest during the period | |||||
| Cash paid for income taxes, net(1) | |||||
| Non-cash information: | |||||
| Loans transferred to other real estate owned | |||||
| Loans transferred to portfolio from held-for-sale at fair value | |||||
| Securities transferred to held-to-maturity from available-for-sale at fair value | |||||
| Available-for-sale securities purchased, not settled | |||||
| Receivable for bank-owned life insurance surrender proceeds | |||||
| Receivable for bank-owned life insurance death benefit proceeds | |||||
| Premises & equipment transferred to held-for-sale | |||||
| Fair value of assets acquired, net of cash received | |||||
| Fair value of liabilities assumed | |||||
| Allowance for credit losses on loans and leases | |||||
| Total allowance for credit losses on loans and leases | |||||
| Retained earnings | |||||
Loading...
